The Global Pacritinib Market is projected to experience substantial growth, driven by increasing global demand for therapeutic innovations in oncology, particularly for myelofibrosis and other hematologic malignancies. The anticipated growth is fueled by regulatory approvals, expanding clinical applications, and ongoing research into Janus kinase (JAK) inhibitors. In this blog, we profile the Top 10 Companies in the Pacritinib Market—a mix of pioneering biopharmaceutical firms, specialized chemical suppliers, and research organizations shaping the future of targeted cancer therapies.

---

🔟 1. CTI BioPharma Corp. (a wholly-owned subsidiary of Sobi)

Headquarters: Seattle, Washington, USA
Key Offering: VONJO® (pacritinib)

CTI BioPharma, now part of Swedish Orphan Biovitrum AB (Sobi), is the originator and primary commercial entity for VONJO® (pacritinib). The company secured U.S. FDA approval for the treatment of adults with intermediate or high-risk primary or secondary myelofibrosis with a platelet count below 50 × 10^9/L. This positions CTI BioPharma as the central innovator in the pacritinib market.

Key Development & Commercial Initiatives:

• Global commercialization and supply of VONJO®
• Ongoing clinical trials to expand pacritinib’s therapeutic indications
• Strategic focus on addressing unmet needs in cytopenic myelofibrosis

Download FREE Sample Report:
Pacritinib Market – View in Detailed Research Report

---

9️⃣ 2. Adooq Bioscience

Headquarters: Irvine, California, USA
Key Offering: High-Purity Pacritinib for Research

Adooq Bioscience is a leading supplier of life science reagents, including small molecule inhibitors like pacritinib. The company provides high-purity compounds specifically for preclinical research and drug discovery applications, supporting academic institutions and biotech companies worldwide.

Research & Supply Chain Initiatives:

• High-quality, well-characterized pacritinib for scientific research
• Robust global distribution network for research chemicals
• Support for early-stage oncology and hematology research

---

8️⃣ 3. Cayman Chemical

Headquarters: Ann Arbor, Michigan, USA
Key Offering: Pacritinib and related biochemical tools

Cayman Chemical is a globally recognized supplier of biochemicals for research, offering pacritinib as part of its extensive portfolio of enzyme inhibitors and signaling molecules. The company serves pharmaceutical, academic, and government research sectors with high-quality reference standards.

Research & Supply Chain Initiatives:

• GMP-grade and research-grade pacritinib options
• Comprehensive analytical data and certificates of analysis
• Support for assay development and high-throughput screening

---

7️⃣ 4. APExBIO Technology

Headquarters: Houston, Texas, USA
Key Offering: Pacritinib for in vitro and in vivo studies

APExBIO Technology specializes in providing high-quality small molecule inhibitors for life science research. The company offers pacritinib with detailed pharmacological data, supporting researchers in oncology and immunology fields.

Research & Supply Chain Initiatives:

• Stable supply chain for research-grade compounds
• Technical support for experimental design
• Global logistics for timely delivery to research facilities

Download FREE Sample Report:
Pacritinib Market – View in Detailed Research Report

---

6️⃣ 5. BioVision

Headquarters: Milpitas, California, USA
Key Offering: Pacritinib and JAK pathway research tools

BioVision provides a comprehensive range of life science research products, including pacritinib for studying JAK-STAT signaling pathways. The company focuses on delivering high-purity compounds with reliable biological activity for research applications.

Research & Supply Chain Initiatives:

• High-purity pacritinib for mechanistic studies
• Companion products for JAK-STAT pathway analysis
• Global distribution to research institutions

---

5️⃣ 6. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: Pacritinib API and intermediates

BOC Sciences is a chemical supplier offering pacritinib active pharmaceutical ingredient (API) and related intermediates for pharmaceutical development and research purposes. The company serves pharmaceutical companies and research organizations worldwide.

Research & Supply Chain Initiatives:

• Custom synthesis and scale-up services
• GMP-compliant manufacturing capabilities
• Quality control and regulatory support

---

4️⃣ 7. MyBiosource

Headquarters: San Diego, California, USA
Key Offering: Pacritinib for biomedical research

MyBiosource supplies pacritinib as part of its extensive catalog of research biochemicals and reagents. The company focuses on providing high-quality products to support drug discovery and basic research in hematological malignancies.

Research & Supply Chain Initiatives:

• Quality-controlled pacritinib batches
• Technical data sheets and application notes
• Global shipping with cold chain logistics

---

3️⃣ 8. TargetMol

Headquarters: Boston, Massachusetts, USA
Key Offering: Pacritinib and targeted compound libraries

TargetMol specializes in providing bioactive small molecules, including pacritinib, for drug discovery and development. The company offers comprehensive compound libraries and screening services for pharmaceutical research.

Research & Supply Chain Initiatives:

• Screening-grade pacritinib for high-throughput applications
• Compound libraries for JAK inhibitor research
• Custom screening and profiling services

---

2️⃣ 9. Selleck Chemicals

Headquarters: Houston, Texas, USA
Key Offering: High-purity pacritinib for research

Selleck Chemicals is a leading global supplier of kinase inhibitors and other bioactive compounds. The company provides pacritinib with comprehensive characterization data, supporting research in myeloproliferative neoplasms and related conditions.

Research & Supply Chain Initiatives:

• Strict quality control protocols
• Batch-to-batch consistency assurance
• Global distribution network

---

1️⃣ 10. AbMole

Headquarters: Wuhan, Hubei, China
Key Offering: Pacritinib for scientific research

AbMole BioScience supplies pacritinib and other small molecule inhibitors to the global research community. The company focuses on providing cost-effective research chemicals with reliable quality and performance characteristics.

Research & Supply Chain Initiatives:

• Competitive pricing for academic research
• Quality assurance and technical support
• Efficient supply chain management

Get Full Report Here:
Pacritinib Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Pacritinib in Hematologic Malignancies

The pacritinib market represents a specialized but crucial segment of the oncology therapeutics landscape. While the clinical application is currently focused on myelofibrosis with thrombocytopenia, the future promises expanded indications and continued research into JAK inhibition mechanisms.

📈 Key Trends Shaping the Market:

• Expanding clinical trials for additional hematologic indications
• Growing understanding of JAK-STAT pathway biology
• Increasing focus on combination therapies in oncology
• Regulatory developments in major pharmaceutical markets

Get Full Report Here:
Pacritinib Market – View in Detailed Research Report

The companies profiled above represent the key stakeholders in the pacritinib ecosystem, from clinical development and commercialization to research supply and scientific support.